These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 11216933)
1. Tolerance of efavirenz in children. Teglas JP; Quartier P; Treluyer JM; Burgard M; Gregoire V; Blanche S AIDS; 2001 Jan; 15(2):241-3. PubMed ID: 11216933 [TBL] [Abstract][Full Text] [Related]
2. Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz. Caso JA; Prieto Jde M; Casas E; Sanz J AIDS; 2001 Jul; 15(11):1447-8. PubMed ID: 11504970 [No Abstract] [Full Text] [Related]
3. Switching from protease inhibitors to the non-nuke efavirenz. TreatmentUpdate; 2001; 12(12):3. PubMed ID: 11570089 [No Abstract] [Full Text] [Related]
4. Effect of first line therapy including efavirenz and two nucleoside reverse transcriptase inhibitors in HIV-infected children. Funk MB; Notheis G; Schuster T; Elanjkal Z; von Hentig N; Stürmer M; Linde R; Dunsch D; Königs C; Wintergerst U; Kreuz W Eur J Med Res; 2005 Dec; 10(12):503-8. PubMed ID: 16356864 [TBL] [Abstract][Full Text] [Related]
5. Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational study. Manfredi R; Calza L; Chiodo F J Acquir Immune Defic Syndr; 2004 Apr; 35(5):492-502. PubMed ID: 15021314 [TBL] [Abstract][Full Text] [Related]
14. [Efavirenz--comprehensive status of studies]. MMW Fortschr Med; 2005 Apr; 147 Spec No 1():79-81. PubMed ID: 16385886 [No Abstract] [Full Text] [Related]
15. Switch to efavirenz in a protease inhibitor-containing regimen. Knechten H; Stürner KH; Höhn C; Braun P HIV Clin Trials; 2001; 2(3):200-4. PubMed ID: 11590528 [TBL] [Abstract][Full Text] [Related]
16. New expanded access drugs for use in combination therapy. Notes Undergr; 1998; (No 37):suppl 1-2. PubMed ID: 11365823 [TBL] [Abstract][Full Text] [Related]
17. NNRTI hepatotoxicity: efavirenz versus nevirapine. Pulido F; Torralba M J HIV Ther; 2002 Nov; 7 Suppl 2():S3-16. PubMed ID: 12735215 [No Abstract] [Full Text] [Related]
18. A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection. Wolbach J; Capoccia K Nurse Pract; 1999 Jun; 24(6):81-2, 87-90, 92. PubMed ID: 10431297 [No Abstract] [Full Text] [Related]